News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BESHAR LUKE M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/08/2023 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 07/05/2022 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $3.1, valued at
$31k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.5, valued at
$35k
|
|
| 03/16/2022 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $4.25, valued at
$42.5k
|
|
| 03/14/2022 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $4.4555, valued at
$44.6k
|
|
| 11/19/2021 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $12.03, valued at
$481.2k
Disposed/sold 6,666 options to buy
@ $0
Disposed/sold 547,656 restricted stock units
@ $0 |
|
| 07/30/2021 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 52,941 options to buy
@ $17, valued at
$900k
|
|
| 07/29/2021 |
3
| BESHAR LUKE M (Director) has filed a Form 3 on Omega Therapeutics, Inc. |
| 06/10/2021 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $10.51, valued at
$105.1k
|
|
| 06/08/2021 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $35.52, valued at
$355.2k
|
|
| 01/04/2021 |
3
| BESHAR LUKE M (Director) has filed a Form 3 on Trillium Therapeutics Inc. |
| 06/11/2020 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $35, valued at
$315k
|
|
| 06/11/2020 |
4/A
| BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 12,399 options to buy
@ $9.18, valued at
$113.8k
Granted 6,676 options to buy
@ $9.18, valued at
$61.3k
|
|
| 06/02/2020 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $37.66, valued at
$376.6k
|
|
| 01/13/2020 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 168,000 shares
@ $0
Granted 12,399 options to buy
@ $9.18, valued at
$113.8k
Granted 6,676 options to buy
@ $9.18, valued at
$61.3k
Granted 10,491 options to buy
@ $9.18, valued at
$96.3k
|
|
| 01/13/2020 |
3
| BESHAR LUKE M (Director) has filed a Form 3 on ArTara Therapeutics, Inc. |
| 06/04/2019 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 10,000 options to buy
@ $43.02, valued at
$430.2k
|
|
| 12/03/2018 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 12,784 shares
@ $65, valued at
$831k
Exercised 12,784 options to buy
@ $3.76, valued at
$48.1k
|
|
| 11/28/2018 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 1,721 shares
@ $65, valued at
$111.9k
Sold 18,786 shares
@ $65.03, valued at
$1.2M
Exercised 1,721 options to buy
@ $49.45, valued at
$85.1k
Exercised 883 options to buy
@ $49.45, valued at
$43.7k
Exercised 4,687 options to buy
@ $22, valued at
$103.1k
Exercised 6,250 options to buy
@ $18.85, valued at
$117.8k
Exercised 6,250 options to buy
@ $12.74, valued at
$79.6k
Exercised 716 options to buy
@ $3.76, valued at
$2.7k
|
|
| 05/30/2018 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $49.45, valued at
$618.1k
|
|
| 05/26/2017 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $18.85, valued at
$235.6k
|
|
| 06/02/2016 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 12,500 options to buy
@ $12.74, valued at
$159.3k
|
|
| 09/22/2015 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 09/17/2015 |
4
| BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 5,208 options to buy
@ $22, valued at
$114.6k
|
|
| 02/24/2015 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 75,201 shares
@ $46, valued at
$3.5M
Disposed/sold 30,615 options to buy
@ $38.27, valued at
$1.2M
Disposed/sold 53,089 options to buy
@ $8.23, valued at
$436.9k
Disposed/sold 14,844 options to buy
@ $8.21, valued at
$121.9k
Disposed/sold 3,594 options to buy
@ $8.25, valued at
$29.7k
Disposed/sold 10,905 restricted stock units
@ $0
Disposed/sold 7,665 restricted stock units
@ $0
Disposed/sold 10,531 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 8,967 shares
@ $0
Paid exercise price by delivering 3,148 shares
@ $45.85, valued at
$144.3k
Paid exercise price by delivering 1,427 shares
@ $45.85, valued at
$65.4k
Paid exercise price by delivering 4,789 shares
@ $45.88, valued at
$219.7k
Granted 10,905 restricted stock units
@ $0
Exercised 3,832 restricted stock units
@ $0
Exercised 10,531 restricted stock units
@ $0
Exercised 3,594 options to buy
@ $8.25, valued at
$29.7k
Exercised 2,969 options to buy
@ $8.21, valued at
$24.4k
Exercised 859 options to buy
@ $38.27, valued at
$32.9k
|
|
| 02/09/2015 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 12/19/2014 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 52,258 shares
@ $35, valued at
$1.8M
Exercised 11,500 options to buy
@ $3.34, valued at
$38.4k
Exercised 8,906 options to buy
@ $8.21, valued at
$73.1k
Exercised 31,852 options to buy
@ $8.23, valued at
$262.1k
|
|
| 11/19/2014 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 47,442 shares
@ $30.008, valued at
$1.4M
Exercised 4,848 options to buy
@ $5.85, valued at
$28.4k
Exercised 31,812 options to buy
@ $3.34, valued at
$106.3k
Exercised 10,782 options to buy
@ $8.25, valued at
$89k
|
|
| 11/04/2014 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $29, valued at
$290k
|
|
| 10/29/2014 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 30,635 shares
@ $26.7539, valued at
$819.6k
|
|
| 08/15/2014 |
4
| BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Exercised 2,462 options to buy
@ $5.85, valued at
$14.4k
Exercised 51,351 options to buy
@ $3.34, valued at
$171.5k
|
|
|
|
|